Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Notice of Proposed Sale · 144

Liquidia Corporation

LQDANASDAQEQUITYCurrent

Notice of Proposed Sale

Filed Sep 14, 2026Accepted Sep 14, 2026, 4:11 PM EDTFiling CIK 1747589Accession 0001950047-26-009384
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
LIQUIDIA CORPORATION
Issuer CIK
0001819576
SEC file number
001-39724
Phone
(919) 328-4400
Person for whose account securities are to be sold
RAMANDEEP SINGH
Relationships to issuer
Director
Street
419 Davis Drive, Suite 100
City
Morrisville,
State / country code
NC
Postal code
27560

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common8,468560,242.8889,508,89109/14/2026NASDAQMorgan Stanley Smith Barney LLC Executive Financial Services

Broker / market maker — proposed row 1, entry 1

Name
Morgan Stanley Smith Barney LLC Executive Financial Services
Street
1 New York Plaza
Street (continued)
8th Floor
City
New York
State / country code
NY
Postal code
10004

Acquisition of securities to be sold

Acquisition of securities to be sold · 1 reported row
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common09/14/2026Stock Option ExerciseIssuer8,468N09/14/2026Cash

Sales reported in the preceding three months

Sales reported in the preceding three months · 1 reported row
SellerSecuritySale dateAmount soldGross proceeds
RAMANDEEP SINGHCommon09/11/20269,024619,209.73

Seller — prior-sale row 1, entry 1

Name
RAMANDEEP SINGH
Street
419 Davis Drive, Suite 100
City
Morrisville,
State / country code
NC
Postal code
27560

Prior-sale reporting

Nothing to report for the preceding three months
N

Notice signature

Notice date
09/14/2026
Signed
Ramandeep Singh

Company context

Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases. The company’s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT® Technology. PRINT enabled the creation of YUTREPIA® (treprostinil) inhalation powder, approved for the treatment of pulmonary arterial hypertension (PAH), and in development for Raynaud’s phenomenon secondary to systemic sclerosis (SSc-RP). The company is also developing L606, an investigational extended-release formulation of treprostinil administered twice daily via a next-generation nebulizer to treat PAH and pulmonary hypertension associated with interstitial lung disease (PH-ILD). To learn more about Liquidia, please visit www.liquidia.com.

Current securities

Recent company filings

  1. Results of Operations and Financial Condition · Other EventsNov 10, 2026
  2. 10-Q filingNov 10, 2026
  3. 4 filingOct 28, 2026
  4. Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement · Regulation FD Disclosure · Other EventsOct 14, 2026
  5. 4 filingOct 13, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.